CRO · Private company
ICON Clinical Research
Track this companyFree. Adds ICON Clinical Research to your Dealase workspace and tells you when its record changes.
Clinical trials254 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired SubpopulationsRECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07654855 · fetched Nov 12, 2026
- Nicotine Pouch Pharmacokinetics Abuse LiabilityPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 8, 2026ClinicalTrials.gov NCT07476144 · fetched Nov 12, 2026
- A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 MonthsPHASE2 · RECRUITING · started Jul 30, 2025ClinicalTrials.gov NCT07126262 · fetched Nov 12, 2026
- Room Air Levels of Harmful and Potentially Harmful Constituents After Heated Tobacco Product Use and CigarettesCOMPLETED · started Jun 10, 2024ClinicalTrials.gov NCT06476405 · fetched Nov 12, 2026
- Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection FractionPHASE2 · COMPLETED · started Dec 20, 2023ClinicalTrials.gov NCT06017609 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)PHASE3 · COMPLETED · started Aug 17, 2023ClinicalTrials.gov NCT05914805 · fetched Nov 12, 2026
- Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor InhibitorsPHASE2 · RECRUITING · started Jul 19, 2023ClinicalTrials.gov NCT05639933 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair LossPHASE3 · COMPLETED · started Jun 21, 2023ClinicalTrials.gov NCT05910450 · fetched Nov 12, 2026
- A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without IbalizumabCOMPLETED · started Mar 22, 2022ClinicalTrials.gov NCT05388474 · fetched Nov 12, 2026
- A Clinical Evaluation of Proof Diagnostics Test System Including the Proof Diagnostics Reader and COVID-19 TestCOMPLETED · started Feb 9, 2022ClinicalTrials.gov NCT05331976 · fetched Nov 12, 2026
- Safety, Tolerability and PK of a Single Subcutaneous Injection of XmAb27564 in Healthy VolunteersPHASE1 · COMPLETED · started Apr 19, 2021ClinicalTrials.gov NCT04857866 · fetched Nov 12, 2026
- A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic TumorsPHASE1_PHASE2 · COMPLETED · started Mar 23, 2021ClinicalTrials.gov NCT04761198 · fetched Nov 12, 2026
- Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)PHASE3 · COMPLETED · started Dec 30, 2019ClinicalTrials.gov NCT04209543 · fetched Nov 12, 2026
- Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant RecipientsPHASE3 · TERMINATED · started Oct 14, 2019ClinicalTrials.gov NCT03744910 · fetched Nov 12, 2026
- Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)PHASE3 · COMPLETED · started Sep 27, 2019ClinicalTrials.gov NCT04090957 · fetched Nov 12, 2026
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsPHASE1 · COMPLETED · started May 29, 2019ClinicalTrials.gov NCT03849469 · fetched Nov 12, 2026
- A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)PHASE2 · COMPLETED · started Mar 23, 2017ClinicalTrials.gov NCT02727699 · fetched Nov 12, 2026
- Helicobacter Pylori Sample Collection Protocol Pre Therapy SubjectsCOMPLETED · started Feb 14, 2017ClinicalTrials.gov NCT03060746 · fetched Nov 12, 2026
- Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic MalignanciesPHASE1 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02924402 · fetched Nov 12, 2026
- PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic MalignanciesPHASE1 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02730312 · fetched Nov 12, 2026
- A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin LymphomaPHASE1_PHASE2 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT01796171 · fetched Nov 12, 2026
- Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to ImatinibPHASE2 · COMPLETED · started Sep 12, 2012ClinicalTrials.gov NCT01593254 · fetched Nov 12, 2026
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world SettingCOMPLETED · started Dec 2, 2010ClinicalTrials.gov NCT01244750 · fetched Nov 12, 2026
- First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-CisplatinPHASE3 · COMPLETED · started Jan 7, 2010ClinicalTrials.gov NCT00981058 · fetched Nov 12, 2026
- Sorafenib Long Term Extension ProgramPHASE3 · COMPLETED · started Dec 21, 2007ClinicalTrials.gov NCT00625378 · fetched Nov 12, 2026